EDGAR Filing Documents for 0001203944-09-000065

Form 8-K - Current report:

SEC Accession No. 0001203944-09-000065

Filing Date

2009-08-25

Accepted

2009-08-25 13:55:50

Documents

Period of Report

2009-08-21

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	RAPTOR FORM 8-K 082509	raptor8k082509.htm	8-K	59379
2	EXHIBIT 4.1 FORM OF WARRANT	formofwarrant.htm	EX-4	56988
3	EXHIBIT 4.2 FORM OF WARRANT PLACEMENT AGENT	formofwarrantagent.htm	EX-4	61212
4	EXHIBIT 99.1 RAPTOR PRESS RELEASE	raptorpressrelease082509.htm	EX-99	24701
5	GRAPHIC	img1.jpg	GRAPHIC	4232
	Complete submission text file	0001203944-09-000065.txt		210031

Mailing Address 9 COMMERCIAL BLVD, SUITE 200 NOVATO CA 94949

Business Address 9 COMMERCIAL BLVD, SUITE 200 NOVATO CA 94949 415-382-1390

RAPTOR PHARMACEUTICALS CORP. (Filer) CIK: 0001203944 (see all company filings)

IRS No.: 980379351 | Fiscal Year End: 0831
Type: 8-K | Act: 34 | File No.: 000-50720 | Film No.: 091033592
SIC: 2834 Pharmaceutical Preparations